Induced Pluripotent Stem Cells

"Induced Pluripotent Stem Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cells from adult organisms that have been reprogrammed into a pluripotential state similar to that of EMBRYONIC STEM CELLS.

Descriptor ID	D057026
MeSH Number(s)	A11.872.040.500 A11.872.700.500
Concept/Terms	Induced Pluripotent Stem Cells Induced Pluripotent Stem Cells IPS Cells Cell, IPS Cells, IPS IPS Cell Human Induced Pluripotent Stem Cells Human Induced Pluripotent Stem Cells hiPSC Fibroblast-Derived Induced Pluripotent Stem Cells Fibroblast-Derived Induced Pluripotent Stem Cells Fibroblast Derived Induced Pluripotent Stem Cells Fibroblast-Derived IPS Cells Cell, Fibroblast-Derived IPS Cells, Fibroblast-Derived IPS Fibroblast Derived IPS Cells Fibroblast-Derived IPS Cell IPS Cell, Fibroblast-Derived IPS Cells, Fibroblast-Derived

Below are MeSH descriptors whose meaning is more general than "Induced Pluripotent Stem Cells".

Anatomy [A]
Cells [A11]
Stem Cells [A11.872]
Adult Stem Cells [A11.872.040]
Induced Pluripotent Stem Cells [A11.872.040.500]
Pluripotent Stem Cells [A11.872.700]
Induced Pluripotent Stem Cells [A11.872.700.500]

Below are MeSH descriptors whose meaning is related to "Induced Pluripotent Stem Cells".

Below are MeSH descriptors whose meaning is more specific than "Induced Pluripotent Stem Cells".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Induced Pluripotent Stem Cells" by people in this website by year, and whether "Induced Pluripotent Stem Cells" was a major or minor topic of these publications.

Bar chart showing 39 publications over 13 distinct years, with a maximum of 6 publications in 2017 and 2018 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	2	0	2
2012	0	1	1
2013	2	1	3
2014	3	0	3
2015	0	1	1
2016	1	0	1
2017	2	4	6
2018	4	2	6
2019	0	2	2
2020	1	1	2
2021	4	2	6
2022	4	0	4
2024	2	0	2

Below are the most recent publications written about "Induced Pluripotent Stem Cells" by people in Profiles.

Arag?n-Gonz?lez A, Shaw AC, Kok JR, Roussel FS, Santos Souza CD, Granger SM, Vetter T, de Diego Y, Meyer KC, Beal SN, Shaw PJ, Ferraiuolo L. C9ORF72 patient-derived endothelial cells drive blood-brain barrier disruption and contribute to neurotoxicity. Fluids Barriers CNS. 2024 Apr 11; 21(1):34.

View in: PubMed
Ropret S, Khurana P, Fabcic T, Cvetkovska J, Trobec A, Jokhadar ?Z, Ilic D, McGrath JA, Guttmann-Gruber C, Liovic M. Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB). Stem Cell Res. 2024 Mar; 75:103306.

View in: PubMed
Zheng Y, Gallegos CM, Xue H, Li S, Kim DH, Zhou H, Xia X, Liu Y, Cao Q. Transplantation of Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Promotes Forelimb Functional Recovery after Cervical Spinal Cord Injury. Cells. 2022 09 05; 11(17).

View in: PubMed
Coulon SJ, Schuman JS, Du Y, Bahrani Fard MR, Ethier CR, Stamer WD. A novel glaucoma approach: Stem cell regeneration of the trabecular meshwork. Prog Retin Eye Res. 2022 09; 90:101063.

View in: PubMed
Choudhery MS, Mahmood R, Harris DT, Ahmad FJ. Minimum criteria for defining induced mesenchymal stem cells. Cell Biol Int. 2022 Jun; 46(6):986-989.

View in: PubMed
Barwe SP, Sebastian A, Sidhu I, Kolb EA, Gopalakrishnapillai A. Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of GATA1 and STAG2 Mutations in Induced Pluripotent Stem Cells with Trisomy 21. Cells. 2022 02 11; 11(4).

View in: PubMed
Sidhu I, Barwe SP, Pillai RK, Gopalakrishnapillai A. Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies. Cells. 2021 10 09; 10(10).

View in: PubMed
Sidhu I, Barwe SP, Kiick KL, Kolb EA, Gopalakrishnapillai A. A 3-D hydrogel based system for hematopoietic differentiation and its use in modeling down syndrome associated transient myeloproliferative disorder. Biomater Sci. 2021 Sep 14; 9(18):6266-6281.

View in: PubMed
Zeidler M, Kummer KK, Sch?pf CL, Kalpachidou T, Kern G, Cader MZ, Kress M. NOCICEPTRA: Gene and microRNA Signatures and Their Trajectories Characterizing Human iPSC-Derived Nociceptor Maturation. Adv Sci (Weinh). 2021 11; 8(21):e2102354.

View in: PubMed
de Jong JO, Llapashtica C, Genestine M, Strauss K, Provenzano F, Sun Y, Zhu H, Cortese GP, Brundu F, Brigatti KW, Corneo B, Migliori B, Tomer R, Kushner SA, Kellendonk C, Javitch JA, Xu B, Markx S. Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder. Nat Commun. 2021 09 01; 12(1):4087.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement